NZ516395A - A method for the treatment or prevention of coronary graft vasospasm - Google Patents
A method for the treatment or prevention of coronary graft vasospasmInfo
- Publication number
- NZ516395A NZ516395A NZ516395A NZ51639500A NZ516395A NZ 516395 A NZ516395 A NZ 516395A NZ 516395 A NZ516395 A NZ 516395A NZ 51639500 A NZ51639500 A NZ 51639500A NZ 516395 A NZ516395 A NZ 516395A
- Authority
- NZ
- New Zealand
- Prior art keywords
- levosimendan
- coronary
- prevention
- medicament
- vasospasm
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Graft Or Block Polymers (AREA)
- Chemical And Physical Treatments For Wood And The Like (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9915179.7A GB9915179D0 (en) | 1999-06-29 | 1999-06-29 | A method for the treatment or prevention of coronary graft vasospasm |
| PCT/FI2000/000592 WO2001000211A1 (en) | 1999-06-29 | 2000-06-29 | A method for the treatment or prevention of coronary graft vasospasm |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ516395A true NZ516395A (en) | 2005-02-25 |
Family
ID=10856266
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ516395A NZ516395A (en) | 1999-06-29 | 2000-06-29 | A method for the treatment or prevention of coronary graft vasospasm |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6593329B1 (de) |
| EP (1) | EP1191935B1 (de) |
| JP (1) | JP4628622B2 (de) |
| KR (1) | KR100762023B1 (de) |
| AT (1) | ATE293446T1 (de) |
| AU (1) | AU767361B2 (de) |
| BR (1) | BR0012072A (de) |
| CA (1) | CA2376930C (de) |
| CZ (1) | CZ294751B6 (de) |
| DE (1) | DE60019591T2 (de) |
| EA (1) | EA004142B1 (de) |
| ES (1) | ES2240110T3 (de) |
| GB (1) | GB9915179D0 (de) |
| HU (1) | HU228302B1 (de) |
| NO (1) | NO320315B1 (de) |
| NZ (1) | NZ516395A (de) |
| PL (1) | PL199973B1 (de) |
| SK (1) | SK285428B6 (de) |
| WO (1) | WO2001000211A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI104718B (fi) * | 1998-06-18 | 2000-03-31 | Orion Yhtymae Oyj | [[4-(2-atsido-3-metyyli-5-oksotetrahydrofuran-2-yyli)fenyyli]hydratsono]propaanidinitriili käytettäväksi referenssiaineena levosimendaanierien analyysissä |
| FI20001542A (fi) * | 2000-06-29 | 2001-12-30 | Orion Yhtymae Oyj | Menetelmä septisen sokin hoitamiseksi |
| JP5781727B2 (ja) * | 2007-02-23 | 2015-09-24 | 株式会社ネクスト２１ | 血管攣縮の治療剤又は予防剤 |
| CA3161960A1 (en) | 2019-12-16 | 2021-06-24 | Tenax Therapeutics, Inc. | Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (ph-hfpef) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2251615B (en) * | 1991-01-03 | 1995-02-08 | Orion Yhtymae Oy | (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile |
| GB2266841A (en) * | 1992-05-06 | 1993-11-17 | Orion Yhtymae Oy | Compounds for use as anti-ischemic medicaments |
| GB9614098D0 (en) * | 1996-07-05 | 1996-09-04 | Orion Yhtymae Oy | Transdermal delivery of levosimendan |
-
1999
- 1999-06-29 GB GBGB9915179.7A patent/GB9915179D0/en not_active Ceased
-
2000
- 2000-06-29 AT AT00942162T patent/ATE293446T1/de active
- 2000-06-29 SK SK1934-2001A patent/SK285428B6/sk not_active IP Right Cessation
- 2000-06-29 CZ CZ20014685A patent/CZ294751B6/cs not_active IP Right Cessation
- 2000-06-29 AU AU56879/00A patent/AU767361B2/en not_active Expired
- 2000-06-29 EA EA200200100A patent/EA004142B1/ru not_active IP Right Cessation
- 2000-06-29 CA CA002376930A patent/CA2376930C/en not_active Expired - Lifetime
- 2000-06-29 BR BR0012072-3A patent/BR0012072A/pt not_active Application Discontinuation
- 2000-06-29 PL PL352779A patent/PL199973B1/pl unknown
- 2000-06-29 WO PCT/FI2000/000592 patent/WO2001000211A1/en active IP Right Grant
- 2000-06-29 JP JP2001505920A patent/JP4628622B2/ja not_active Expired - Lifetime
- 2000-06-29 US US10/019,392 patent/US6593329B1/en not_active Expired - Lifetime
- 2000-06-29 ES ES00942162T patent/ES2240110T3/es not_active Expired - Lifetime
- 2000-06-29 DE DE60019591T patent/DE60019591T2/de not_active Expired - Lifetime
- 2000-06-29 NZ NZ516395A patent/NZ516395A/en not_active IP Right Cessation
- 2000-06-29 EP EP00942162A patent/EP1191935B1/de not_active Expired - Lifetime
- 2000-06-29 KR KR1020017016395A patent/KR100762023B1/ko active IP Right Grant
- 2000-06-29 HU HU0202085A patent/HU228302B1/hu unknown
-
2001
- 2001-12-21 NO NO20016316A patent/NO320315B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ294751B6 (cs) | 2005-03-16 |
| BR0012072A (pt) | 2002-04-02 |
| HUP0202085A3 (en) | 2003-02-28 |
| PL199973B1 (pl) | 2008-11-28 |
| EP1191935B1 (de) | 2005-04-20 |
| WO2001000211A1 (en) | 2001-01-04 |
| AU5687900A (en) | 2001-01-31 |
| SK19342001A3 (sk) | 2002-07-02 |
| GB9915179D0 (en) | 1999-09-01 |
| JP2003503353A (ja) | 2003-01-28 |
| NO20016316D0 (no) | 2001-12-21 |
| ES2240110T3 (es) | 2005-10-16 |
| CA2376930C (en) | 2008-07-29 |
| EA004142B1 (ru) | 2004-02-26 |
| KR100762023B1 (ko) | 2007-10-04 |
| HUP0202085A2 (hu) | 2002-12-28 |
| US6593329B1 (en) | 2003-07-15 |
| PL352779A1 (en) | 2003-09-08 |
| DE60019591D1 (de) | 2005-05-25 |
| EA200200100A1 (ru) | 2002-06-27 |
| DE60019591T2 (de) | 2006-03-02 |
| EP1191935A1 (de) | 2002-04-03 |
| CA2376930A1 (en) | 2001-01-04 |
| SK285428B6 (sk) | 2007-01-04 |
| NO320315B1 (no) | 2005-11-21 |
| AU767361B2 (en) | 2003-11-06 |
| NO20016316L (no) | 2002-01-30 |
| HU228302B1 (en) | 2013-03-28 |
| JP4628622B2 (ja) | 2011-02-09 |
| CZ20014685A3 (cs) | 2002-08-14 |
| KR20020020743A (ko) | 2002-03-15 |
| ATE293446T1 (de) | 2005-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2376930C (en) | A method for the treatment or prevention of coronary graft vasospasm | |
| CA2335280C (en) | Method of treating pulmonary hypertension | |
| EP1408977A1 (de) | Kombinationstherapie zur behandlung von herzinsuffizienz | |
| EP1401450B1 (de) | Verwendung eines pyridazinon derivates zur behandlung des kongestiven herzversagens | |
| CA2412213C (en) | A method for treating septic shock | |
| CA2387920C (en) | A new use of levosimendan |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 7 YEARS UNTIL 29 JUN 2020 BY DENNEMEYER SA Effective date: 20130516 |
|
| EXPY | Patent expired |